The DOI matches its Crossref record.
Generation of rac3 Null Mutant Mice: Role of Rac3 in Bcr/Abl-Caused Lymphoblastic Leukemia
Abstract
Numerous studies indirectly implicate Rac GTPases in cancer. To investigate if Rac3 contributes to normal or malignant cell function, we generated rac3 null mutants through gene targeting. These mice were viable, fertile, and lacked an obvious external phenotype. This shows Rac3 function is dispensable for embryonic development. Bcr/Abl is a deregulated tyrosine kinase that causes chronic myelogenous leukemia and Ph-positive acute lymphoblastic leukemia in humans. Vav1, a hematopoiesis-specific exchange factor for Rac, was constitutively tyrosine phosphorylated in primary lymphomas from Bcr/Abl P190 transgenic mice, suggesting inappropriate Rac activation. rac3 is expressed in these malignant hematopoietic cells. Using lysates from BCR/ABL transgenic mice that express or lack rac3, we detected the presence of activated Rac3 but not Rac1 or Rac2 in the malignant precursor B-lineage lymphoblasts. In addition, in female P190 BCR/ABL transgenic mice, lack of rac3 was associated with a longer average survival. These data are the first to directly show a stimulatory role for Rac in leukemia in vivo. Moreover, our data suggest that interference with Rac3 activity, for example, by using geranyl-geranyltransferase inhibitors, may provide a positive clinical benefit for patients with Ph-positive acute lymphoblastic leukemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence also suggests that Rac3 plays a role in p190-BCR-ABL-mediated ALL, while Rac1 and Rac2 do not appear to be hyperactivated in these lymphoma lysates (Cho et al., 2005).”
From Rac Guanosine Triphosphatases Represent Integrating Molecular Therapeutic Targets for BCR-ABL-Induced Myeloproliferative Disease (2007) · cites this paper as Cho et al., 2005
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 48
- Aghazadeh B., 2000, Cell, 102, 625, 10.1016/S0092-8674(00)00085-4 · DOI
- Bassermann F., 2002, J. Biol. Chem., 277, 12437, 10.1074/jbc.M112397200 · DOI · Paper page
- Benard V., 1999, J. Biol. Chem., 274, 13198, 10.1074/jbc.274.19.13198 · DOI · Paper page
- Bolis A., 2003, Eur. J. Neurosci., 18, 2417, 10.1046/j.1460-9568.2003.02938.x · DOI
- Crespo P., 1997, Nature, 385, 169, 10.1038/385169a0 · DOI
- Danhauser-Riedl S., 1996, Cancer Res., 56, 3589
- Glogauer M., 2003, J. Immunol., 170, 5652, 10.4049/jimmunol.170.11.5652 · DOI
- Groffen J., 1997, Baillieres Clin. Haematol., 10, 187, 10.1016/S0950-3536(97)80002-9 · DOI
- Gu Y., 2003, Science, 302, 445, 10.1126/science.1088485 · DOI · Paper page
- Haataja L., 1997, J. Biol. Chem., 272, 20384, 10.1074/jbc.272.33.20384 · DOI · Paper page
- Habets G. G., 1995, Cytogenet. Cell. Genet., 70, 48, 10.1159/000133989 · DOI
- Haeusler L. C., 2003, FEBS Lett., 555, 556, 10.1016/S0014-5793(03)01351-6 · DOI · Paper page
- Hall A, 1998, Science, 279, 509, 10.1126/science.279.5350.509 · DOI
- Han J., 1997, Mol. Cell. Biol., 17, 1346, 10.1128/MCB.17.3.1346 · DOI
- Hardy R. R., 1991, J. Exp. Med., 173, 1213, 10.1084/jem.173.5.1213 · DOI
- Harnois T., 2003, Oncogene, 22, 6445, 10.1038/sj.onc.1206626 · DOI · Paper page
- Heisterkamp N., 1990, Nature, 344, 251, 10.1038/344251a0 · DOI
- Heisterkamp N., 2002, Oncogene, 21, 8536, 10.1038/sj.onc.1206080 · DOI
- Hemmeryckx B., 2001, Cancer Res., 61, 1398
- Hu Y., 2004, Nat. Genet., 36, 453, 10.1038/ng1343 · DOI
- Joneson T., 1996, Science, 274, 1374, 10.1126/science.274.5291.1374 · DOI
- Joyce P. L., 2003, Cancer Res., 63, 7959
- Kaartinen V., 2001, Development, 128, 4217, 10.1242/dev.128.21.4217 · DOI
- Katzav S., 1989, EMBO J., 8, 2283, 10.1002/j.1460-2075.1989.tb08354.x · DOI · Paper page
- Khosravi-Far R., 1995, Mol. Cell. Biol., 15, 6443, 10.1128/MCB.15.11.6443 · DOI · Paper page
- Lamarche N., 1996, Cell, 87, 519, 10.1016/S0092-8674(00)81371-9 · DOI
- Leung K., 2003, Cells Tissues Organs, 175, 72, 10.1159/000073751 · DOI
- Li Y. S., 1993, J. Exp. Med., 178, 951, 10.1084/jem.178.3.951 · DOI
- Malosio M. L., 1997, J. Neurosci., 17, 6717, 10.1523/JNEUROSCI.17-17-06717.1997 · DOI
- Mareel M., 2003, Physiol. Rev., 83, 337, 10.1152/physrev.00024.2002 · DOI
- Matsuguchi T., 1995, EMBO J., 14, 257, 10.1002/j.1460-2075.1995.tb06999.x · DOI
- Mira J. P., 2000, Proc. Natl. Acad. Sci. USA, 97, 185, 10.1073/pnas.97.1.185 · DOI
- Mishra S., 2003, Oncogene, 22, 8255, 10.1038/sj.onc.1207156 · DOI
- Nimnual A. S., 1998, Science, 279, 560, 10.1126/science.279.5350.560 · DOI
- Olson M. F., 1995, Science, 269, 1270, 10.1126/science.7652575 · DOI
- Ptasznik A., 2004, Nat. Med., 10, 1187, 10.1038/nm1127 · DOI
- Qiu R-G., 1995, Nature, 374, 457, 10.1038/374457a0 · DOI
- Roberts A. W., 1999, Immunity, 10, 183, 10.1016/S1074-7613(00)80019-9 · DOI · Paper page
- Scita G., 1999, Nature, 401, 290, 10.1038/45822 · DOI
- Skorski T., 1998, Proc. Natl. Acad. Sci. USA, 95, 11858, 10.1073/pnas.95.20.11858 · DOI · Paper page
- Stanley E. R, 1997, Methods Mol. Biol, 75, 301
- Sugihara K., 1998, Oncogene, 17, 3427, 10.1038/sj.onc.1202595 · DOI
- Van Aelst L., 1997, Genes Dev., 11, 2295, 10.1101/gad.11.18.2295 · DOI
- Voncken J. W., 1992, Cancer Res., 52, 4534
- Voncken J. W., 1998, Oncogene, 16, 2029, 10.1038/sj.onc.1201730 · DOI
- Walmsley M. J., 2003, Science, 302, 459, 10.1126/science.1089709 · DOI · Paper page
- Westwick J. K., 1997, Mol. Cell. Biol., 17, 1324, 10.1128/MCB.17.3.1324 · DOI
- Zhao X., 2003, J. Biol. Chem., 278, 40788, 10.1074/jbc.M302208200 · DOI
Cited by
Thomas, E. K., Cancelas, J. A., Chae, H.-D., Cox, A. D., Keller, P. J., Perrotti, D., Neviani, P., Druker, B. J., Setchell, K. D. R., Zheng, Y., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.015 · Cited by 147
Pai, S.-Y., Kim, C., & Williams, D. A. (2010) · Disease Markers · doi:10.1155/2010/380291 · Cited by 85
Metadata
- Authors
- Cho, Y. J., Zhang, B., Kaartinen, V., Haataja, L., de Curtis, I., Groffen, J., & Heisterkamp, N.
- Affiliations
- Section of Molecular Carcinogenesis, Division of Hematology/Oncology
- Developmental Biology Program, Departments of Pathology and Surgery, Childrens Hospital Los Angeles, and Saban Research Institute and Keck School of Medicine, University of Southern California, Los Angeles, California
- Cell Adhesion Unit, Department of Molecular Biology and Functional Genomics, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2005-07-01
- Volume
- 25
- Issue
- 13
- Pages
- 5777-5785
- ISSN
- 1098-5549
- Cited by
- 50
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Generation of rac3 Null Mutant Mice: Role of Rac3 in Bcr/Abl-Caused Lymphoblastic Leukemia. https://app.cochat.ai/papers/10.1128/mcb.25.13.5777-5785.2005
- The paper
- Cho, Y. J., Zhang, B., Kaartinen, V., Haataja, L., de Curtis, I., Groffen, J., & Heisterkamp, N. (2005). Generation of rac3 Null Mutant Mice: Role of Rac3 in Bcr/Abl-Caused Lymphoblastic Leukemia. Molecular and Cellular Biology. https://doi.org/10.1128/mcb.25.13.5777-5785.2005